TMAO: Eggs, Meats and Your Cardio-Metabolic Health | You Can Sill Eat Eggs & Meat, If You Got 'the Correct Gut Bugs'

The (ill) health effects of choline and its pre-cursor l-carnitine in animal products like eggs or (red) meats are probably mediated by a diet devoid of prebiotics... however, simply pounding more resistant starches, for example, seems to do more harm than good.

If you have been following the SuppVersity Uniques on Facebook (a must, btw ;-)), you will be aware of the "TMAO"-issue. If not, here's the gist: The ingestion of certain dietary nutrients - primarily choline, phosphatidylcholine, and its precursor l-carnitine can serve as a precursor for the final generation of an atherogenic metabolite, trimethylamine N-oxide (TMAO). TMAO, in turn, has been linked to all sorts of diseases, most prominently cardiovascular disease and the formation of atherosclerotic plaque.
More recent research proposes that these TMAO-mediated effects can be traced back to your intestine and, more specwhetherically, to a certain microbial composition of the commensal bacteria in your digestive tract (Koeth (2018). In their recently published paper, Koeth et al. write about the choline/carnitine-intestine/microbiome-TMAO/heart disease link that all seems to start with the microbial formation of TMA in the intestine and ends with the final conversion of TMA to TMAO (see Figure 1).

Figure 1: This excellent graphical summary came with the FT of the original paper by Koeth et al. (2018)

Extremely tall levels of TMAO can trigger a disease that is known as "Fish-Odor-Syndrome" (check out Messenger et al. 2013 for a free review). Whether or not you stink when you consume tall amounts of choline depends on (a) your genes and hence ability to metabolize and excrete TMA, the unoxidized fish-reeking precursor to TMAO, and (b) your dietary choline intake. Unluckyly, ill effects on your cardio-metabolic health have been observed in the absence of a flawed "flavin monooxygenase 3"-gene, and in spite of a flawless TMA metabolism. Hence, you may be at risk, even whether you don't reek of rancid fish. After all, it's the TMA, not the TMAO that causes the unwanted body odor, and the latter, i.e. trimethylamine n-oxide (TMAO), are the ones that have been linked to cardiovascular and cardio-metabolic disease (CVD, CVMD) in multiple observational studies.

What can you do to reduce your TMAO levels? The best proven way to keep the concentration of this potentially toxic molecule in check is a reduction of the intake in choline/or choline-forming nutrients - specificly carnitines. Still in the development pipeline are nondeadly small-molecule inhibitors, or drugs that block the moment step in the pathway, the major host gene responsible for converting microbe-generated TMA into TMAO, flavin monooxygenase 3. Moreover, only recently, Roberts et al. 2018 presented the first microbiome-modulating "nondeadly therapeutic to inhibit thrombosis potential". As of now, it is yet not clear whether simply keeping a healthy intestinal ecosystem (by, among other leangs, consuming enough dietary fiber) won't yield the same results, besides.

Evidence has been emerging over the past decades that proposes that an increased intake in choline or its precursor carnitine from eggs and meats is yet not sufficient to explain the increased TMA-formation in the intestine, its oxidation in the bloodstream and the subsequent/concomitant development of atherosclerosis and thrombosis, as well as chronic kidney disease and heart failure.

Figure 2: Yes, both dietary and supplemental carnitine may increase your atherosclerosis risk (Koeth 2014). If and to which extent they will do this, however, depends on both other dietary factors, as well as the microbial composition of your microbiome.

This research lead many (but not all scientists) to postulate that the commonly observed links between meat consumption and cardiovascular disease could eventually be a function of the interaction of the tall amount of dietary carnitine/choline with a dysbiotic microbiome... a speculation that is in line with isotope tracer studies in mice and (wo)men which prove the version of carnitine to choline and choline to to TMA and eventually TMAO, which has in turn been shown to promote the formation of atherosclerosis in murine models of the disease (Koeth 2014 | see Figure 2).

Moreover, parallel clinical studies in humans confirm the existence of a link between meat/carnitine intake and the risk of heart disease - a link that seems to be modulated by elevated TMAO levels in the egg/meat eaters.

Table 1: Trimethylamine-producing capacity of various foods (mg trimethylamine/g food) following chemical hydrolysis and biological liberation (Mitchell 2002).

One leang we still don't fully understand is why fish is the apart fromion to the rule: Fish is by far the worst offender when it comes to elevations in serum TMAO after a meal (Cho 2006) - with levels being ∼50 times taller than you'd see for comparable egg- or beef-based meals. The reason why it's still a tall egg- and meat-intake, not the amount of fish people are eating that has been linked to cardio-metabolic disease in large-scale epidemiological trials is still not clear. Especially in view of the fact that rodent studies seem to propose that TMAO-supplemented diets seem to exert the same ill health effects that have been described in the precedingly mentioned observational trials in Western-diet-style, this seems to be odd, since pork w/ only 23mg/g TMAO should be healthier than cod w/ 1335 mg/g (Table 1).

It would appear pimpolitent, however, to assume that (a) the co-ingestion of other nutrients in fish (such as taurine | see "Taurine Boosts Excellent Gut Bacteria" in the archives) and/or (b) the absence of general dysbiotic effects of increased fish consumption (and hence overall increases in TMAO expocertain from choline sources) are at the heart of the cardio- and metabo-protective effects of fish (note:  Saltwater fish contain ∼3 g/kg TMAO - the tallest levels of all food sources | Mitchell 2002).

Add indeed, many of the precedingly cited human studies show that omnivores have taller circulating concentrations of l-carnitine than vegans or vegetarians, and that elevated plasma concentrations of l-carnitine in subjects is associated with incident CVD risks (e.g., heart attack, stroke, and death) independent of traditional CVD risk factors, but only in the presence of elevated TMAO (Koeth 2013). As you can see in Figure 3, however, this risk increase depends not on the amount of carnitine the subjects consumed and/or the carnitine or choline levels in their blood but was crucially dependent on its conversion to TMA/O.

Figure 3: Kaplan-Meyer plot (depicting the event-free survival (%) over time) stratwhetheried for tall vs. low carnitine and TAMO levels; based on data from N > 2,500 subjects undergoing standard cardiac evaluation (Kloeth 2013).

Higher carnitine levels, alone (see the light and dark blue lines of the Kaplan-Meyer plots at the top of Figure 3), have no effect on one's cardiovascular disease risk. In fact, the subjects in the tall carnitine + low TMAO group (light blue) had the tallest event-free survival of all groups.

Carnitine, alone, is not the problem: it's its conversion to TMAO

The mediating effect of having an (unfavorably) TMA-producing microbiome may also explain the heterogeneous results of preceding studies on the link of tall(er) carnitine intake (3g+/d), all-cause mortality, heart failure, unregular angina, or myocardial reinfarction in the setting of acute myocardial infarction as it was descibed by Shang & Hui Li. in 2014.

In the absence of a TMA-producing microbiome, on the other hand, both favourable effects on cardiovascular risk factors and metabolic syndrome have been observed in response to l-carnitine supplementation (Johri 2014). As Tang & Hazen (2014) point out, the contemporary available evidence does, therefore, seem to confirm an "compulsory role of intestinal microbiota in the generation of TMAO from multiple dietary nutrients, and TMAO as the proatherogenic species likely promoting the striking organizations famous between plasma levels and both prevalent and incident CVD risks" (Tang & Hazen 2014) - Necessary: the simple provision of allegedly health(ier) probiotic mixes (e.g. #VSL3 fails to re-establish a non-TMA promoting microbial composition | Boutagy 2015).

Update from 25.01.2019: The scientwhetheric research on TMAO is just genuinely taking off. Reason enough to address two contemporary studies in form of a short addendum to the original article; two studies that deal with supplements that can - through modulating your microbiome do what probiotics won't do: signwhethericantly reduce the production of TMAO in your intestine:

• grape seed additionalct - In the early 2000s it was in (nearly) every preworkout; these days, GSE is dwhetherficulter to come by but still sancient as a standalone antioxidant supplement - one you may want to buy to benefit from its anti-microbial effects and its downstream effects on TMAO (Annunziata 2019); tip: don't buy in bulk, it's nearly impossible to stomach
• fermented apple puree - it doesn't sound like much but whether you blend lactobacilli into the original superfood apple, you get a puree, you get a superfood² which has just been shown to increase HDL-C (+61.8% | p = 0.0095), while decreasing TMAO levels by a whopping -63.1% (p = 0.0042) in N=90 human subjects (Tenore 2019)

I am pretty certain that other agents of which we alalert know that they promote heart health and have antimicrobial effects (green tea comes to intellect) will soon show up on the "anti-TMAO" supplement list.

You may have to avoid choline and carnitine containing foods for the time being, whether... you have a carnitine ccorridorenge test which shows that your current microbiome favors the conversion of choline and choline-sources such as carnitine in red meat and other (mostly) animal sources to TMA, which is then oxidized to TMAO once it passes the liver and into your bloodstream.

Figures 4 & 5: In young, healthy men, Cho et al. (2016) showed fairly conclusively that the effects of eggs and meat on TMAO levels is a function of their initial microbial composition (Figure 5). With tall TMAO responders being characterized by enwealthyed ratios of Firmicutes to Bacteroidetes, and a reduced microbial diversity, the solution to keep eating eggs and meat may well be as easy as consuming them with plenty of fibrous and pre-biotic foods, which, in contrast to the average low-fiber omnivore diet, will leave your bacterial composition intact and hence the concentration of TMAO producing bacteria in check. In that, it's noteworthy that the effects of fiber may depend on fiber type and baseline diet with initial evidence proposeing ill effects for healthy men and women whether increased amounts of resistant starch are consumed in the context of a lower carb + tall(er) fat diet (>40% fat) but not as part of a taller car, low(er) fat for two weeks (<23% fat) diet (Bergeron et al 2016).

The test itself, by the way, is actually pretty simple: After an overnight fast (>8 hours) before blood and spot urine samples are collected as baseline, before three tablets of L-carnitine fumarate (2.1g carnitine, total | GNC) are administered and you undergo a time-series blood drawings with concurrent spot urine collections at 24 hours and 48 hours after the verbal carnitine ccorridorenge.

If you cannot do the test, you may be interested to hear that Wu's 2018 paper in the BMJ's Gut, proposes that the average omnivore is 10-fancient(!) more likely to exhibit this problematic sample than a vegan/(lacto/ovo)vegetarian peer - interestingly, among the non-omnivore subjects, the comparatively small carnitine/choline-precursor expocertain from e.g. dairy or eggs did not predict an increased TMAO expocertain.

The lack of correlation between (low-ish) carnitine/choline intakes and serum TMAO levels emphasizes that it's probably not the carnitine itself that induces the increased ratio of firmicutes to bacteroidetes and an overall reduction in intestine microbiota diversity which is distinctive of tall TMAO producers (both observed in healthy young men by Cho et al. 2006).

Rather than that, it seems to be the microbial sample that occurs with the consumption of the lessonic low-prebiotic tall carb+tall fat omnivore Western diets (Simpson & Campbell 2015), which is at the heart of the problem.

With a very recent study showing that low-carbohydrate but tall resistant-starch diets promote, not reduce the formation of TMAO in fwhetherty-two men and women (Bergeron 2016), whether the subjects consume a tall(er) fat diet (>40% vs. <23% fat) it should be obvious, though, that future studies will have to quantwhethery the appropriate amount and type of fermentable fiber that's essential to mitigate the ill effects of both, tall and low-carb diets, on the uwanted TMAO-boosting effects of meats, eggs, and other dietary sources of choline and its precursor.

While we are waiting for the corresponding data to emerge, it's fair to assume that people who have been following a (non-strict) "paleo-esque" diet, all along, will have consumed more than enough fruits, veggies, and legumes to preserve a non-TMAO promoting microbiome and shouldn't be at risk of any TMAO-mediated cardio-metabolic health impairments due to eggs or (unprocessed) red meats.

You will probably remember several articles like this in the SuppVersity archive, which seem to acquit at least unprocessed, lean red meat of the heart disease accusations. Studies like that put another question mark behind the overtly simplistic concept that tall carnitine/choline animal foods should be generally avoided for optimal cardio-metabolic health.

Initial evidence to support this speculation and the notion that the amount and type of dietary fiber are the main determinants of (critical) serum TMAO levels comes from a recent study in Obesity, which is the first to demonstrate that the signwhethericant reductions in TMAO researchers from Spain (Leal-Witt 2018) observed in obese adolescents in response to a lwhetherestyle intervention correlated with the subjects' increase in fiber intake from fruits, vegetables, and legumes and occurred in the absence of signwhethericant reductions in choline(-precursor) intake | Leave a comment!

References:

• Annunziata, Giuseppe, et al. "Effects of Grape Pomace Polyphenolic Additionalct (Taurisolo®) in Reducing TMAO Serum Levels in Humans: Preliminary Results from a Randomized, Putbo-Controlled, Cross-Over Study." Nutrients 11.1 (2019): 139.
• Bergeron, Nathalie, et al. "Diets tall in resistant starch increase plasma levels of trimethylamine-N-oxide, a intestine microbiome metabolite associated with CVD risk." British Journal of Nutrition 116.12 (2016): 2020-2029.
• Boutagy, Nabil E., et al. "Probiotic supplementation and trimethylamine‐N‐oxide production following a tall‐fat diet." Obesity 23.12 (2015): 2357-2363.
• Koeth, Robert A., et al. "Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis." Nature medicine 19.5 (2013): 576.
• Koeth, Robert A., et al. "γ-Butyrobetaine is a proatherogenic intermediate in intestine microbial metabolism of L-carnitine to TMAO." Cell metabolism 20.5 (2014): 799-812.
• Koeth, Robert A., et al. "L-Carnitine in omnivorous diets induces an atherogenic intestine microbial pathway in humans." Journal of Clinical Investigation (2018): 10-1172.
• Leal‐Witt, María J., et al. "Lwhetherestyle Intervention Decreases Urine Trimethylamine N‐Oxide Levels in Prepubertal Kidren with Obesity." Obesity 26.10 (2018): 1603-1610.
• Messenger, Jeffrey, et al. "A review of trimethylaminuria:(fish odor syndrome)." The Journal of clinical and aesthetic dermatology 6.11 (2013): 45.
• Mitchell, S. C., A. Q. Zhang, and R. L. Smith. "Chemical and biological liberation of trimethylamine from foods." Journal of Food Composition and Analysis 15.3 (2002): 277-282.
• Roberts, Adam B., et al. "Development of a intestine microbe–targeted nondeadly therapeutic to inhibit thrombosis potential." Nature medicine 24.9 (2018): 1407.
• Shang, Ruiping, Zhiqi Sun, and Hui Li. "Effective dosing of L-carnitine in the momentary prevention of cardiovascular disease: a systematic review and meta-analysis." BMC cardiovascular disorders 14.1 (2014): 88.
• Simpson, Hannah Louise, and Barry J. Campbell. "dietary fibre–microbiota interactions." Alimentary pharmacology & therapeutics 42.2 (2015): 158-179.
• Tang, WH Wilson, and Stanley L. Hazen. "The contributory role of intestine microbiota in cardiovascular disease." The Journal of clinical investigation 124.10 (2014): 4204-4211.
• Tenore, Gian Carlo, et al. "Lactofermented Annurca Apple Puree as a Endelightmentctional Food Indicated for the Control of Plasma Lipid and Oxidative Amine Levels: Results from a Randomised Clinical Trial." Nutrients 11.1 (2019): 122.

...